CymitQuimica logo

CAS 387867-13-2

:

4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide

Description:
The chemical substance known as 4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide, with CAS number 387867-13-2, is a synthetic compound that belongs to the class of quinazoline derivatives. It is characterized by its complex molecular structure, which includes a quinazoline core, a piperazine moiety, and various functional groups such as methoxy and propoxy substituents. This compound exhibits potential pharmacological properties, often investigated for its role in modulating biological pathways, particularly in the context of neurological or psychiatric disorders. Its structure suggests possible interactions with specific receptors or enzymes, making it a candidate for drug development. The presence of the piperidine and piperazine rings may contribute to its lipophilicity and ability to cross biological membranes. As with many synthetic compounds, its solubility, stability, and reactivity can vary based on environmental conditions and the presence of other substances. Further studies are typically required to fully elucidate its biological activity and therapeutic potential.
Formula:C31H42N6O4
InChI:InChI=1/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)
InChI key:InChIKey=UXXQOJXBIDBUAC-UHFFFAOYSA-N
SMILES:CC(C)Oc1ccc(cc1)NC(=O)N1CCN(CC1)c1c2cc(c(cc2ncn1)OCCCN1CCCCC1)OC
Synonyms:
  • (4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide
  • 1-Piperazinecarboxamide, 4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-
  • 4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide
  • 4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide
  • Ct 53518
  • Mln 0518
  • Mln 518
  • Tandutinib
  • Tandutinib(TINIBS)
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
  • Tandutinib

    CAS:
    Formula:C31H42N6O4
    Purity:98%
    Color and Shape:Solid
    Molecular weight:562.7030

    Ref: IN-DA007842

    ne
    To inquire
    25mg
    51.00€
    50mg
    72.00€
    100mg
    108.00€
    250mg
    187.00€
  • Tandutinib

    CAS:
    Tandutinib
    Formula:C31H42N6O4
    Purity:≥98%
    Molecular weight:562.7

    Ref: 54-BUP14092

    25mg
    61.00€
    50mg
    85.00€
    100mg
    111.00€
    200mg
    154.00€
  • N-(4-Isopropoxyphenyl)-4-(6-Methoxy-7-(3-(Piperidin-1-Yl)Propoxy)Quinazolin-4-Yl)Piperazine-1-Carboxamide

    CAS:
    N-(4-Isopropoxyphenyl)-4-(6-Methoxy-7-(3-(Piperidin-1-Yl)Propoxy)Quinazolin-4-Yl)Piperazine-1-Carboxamide
    Formula:C31H42N6O4
    Purity:99%
    Molecular weight:562.7

    Ref: 54-OR1026219

    50mg
    80.00€
    100mg
    110.00€
    250mg
    180.00€
  • Tandutinib

    CAS:
    Tandutinib (CT53518) (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 μM), can also inhibit c-Kit and PDGFR, 15-20 fold higher potency for FLT3
    Formula:C31H42N6O4
    Purity:99.45% - ≥98%
    Color and Shape:Solid
    Molecular weight:562.7

    Ref: TM-T1667

    25mg
    43.00€
    1mL*10mM (DMSO)
    55.00€
    50mg
    56.00€
    100mg
    75.00€
    200mg
    95.00€
  • Tandutinib

    CAS:
    Formula:C31H42N6O4
    Molecular weight:562.71

    Ref: 7W-GP3628

    1mg
    160.00€
    5mg
    202.00€
    10mg
    229.00€
  • Tandutinib

    Controlled Product
    CAS:

    Applications An oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) and other cancer indications. The drug exhibited limited activity as a single agent in phase I and II clinical trials in patients with AML and myelodysplastic syndrome, but displayed promising antileukemic activity (90% complete remissions) in a phase I/II trial in patients with newly diagnosed AML when administered in combination with cytarabine and daunorubicin.
    References Manning, G., et al.: Science, 298, 1912 (2002), Lombardo, L., et al.: J. Med. Chem., 47, 6658 (2004), Knight, Z., et al.: Chem. Biol., 12, 621 (2005), Baselga, J., et al.: Science, 312, 1175 (2006), Garber, K., et al.: Nat. Biotechnol., 24, 127 (2006), Flaherty, K., et al.: Clin. Cancer Res., 13, 747 (2007),

    Formula:C31H42N6O4
    Color and Shape:Neat
    Molecular weight:562.7

    Ref: TR-T006550

    25mg
    89.00€
    50mg
    122.00€
    100mg
    188.00€
  • Tandutinib

    CAS:

    Tyrosine kinase inhibitor; antineoplastic activity; pro-apoptotic

    Formula:C31H42N6O4
    Purity:Min. 95%
    Color and Shape:Powder
    Molecular weight:562.7 g/mol

    Ref: 3D-FT28001

    250mg
    186.00€
  • Tandutinib

    CAS:
    N-(4-Isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide
    Formula:C31H42N6O4
    Purity:99%
    Molecular weight:562.7